Viewing Study NCT00793234


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-05-24 @ 9:03 AM
Study NCT ID: NCT00793234
Status: COMPLETED
Last Update Posted: 2014-04-07
First Post: 2008-11-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
Sponsor: ThromboGenics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Total Knee Replacement Surgery View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TKR View
None VTE View
None DVT View